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AbsTrACT
background/aims To report alterations in visual acuity 
and visual pathway structure over an interval of 1–3 years 
in a cohort of children, adolescents and young adults who 
have Wolfram syndrome (WFS) and to describe the range 
of disease severity evident in patients with WFS whose 
ages differed by as much as 20 years at first examination.
Methods Annual, prospective ophthalmological 
examinations were performed in conjunction with retinal 
nerve fibre layer (RNFL) analysis. Diffusion tensor MRI-
derived fractional anisotropy was used to assess the 
microstructural integrity of the optic radiations (OR FA).
results Mean age of the 23 patients with WFS in 
the study was 13.8 years (range 5–25 years). Mean 
log minimum angle resolution visual acuity was 0.66 
(20/91). RNFL thickness was subnormal in even the 
youngest patients with WFS. Average RNFL thickness in 
patients with WFS was 57±8 µ or ~40% thinner than that 
measured in normal (94±10 µ) children and adolescents 
(P<0.01). Lower OR FA correlated with worse visual acuity 
(P=0.006). Subsequent examinations showed declines 
(P<0.05) in visual acuity, RNFL thickness and OR FA at 
follow-up intervals of 12–36 months. However, a wide 
range of disease severity was evident across ages: some 
of the youngest patients at their first examination had 
deficits more severe than the oldest patients.
Conclusion The genetic mutation of WFS causes 
damage to both pregeniculate and postgeniculate regions 
of the visual pathway. The damage is progressive. The 
decline in visual pathway structure is accompanied by 
declines of visual function. Disease severity differs widely 
in individual patients and cannot be predicted from their 
age.
InTroduCTIon 
Wolfram syndrome (WFS), also known as 
DIDMOAD, was first described in 1938 by 
Wolfram and Wagener.1 It is a rare, auto-
somal recessive syndrome characterised by 
a cluster of symptoms including diabetes 
insipidus (DI), diabetes mellitus (DM), 
optic nerve atrophy (OA) and sensorineural 
deafness (D). WFS can result in a shortened 
lifespan.2 3 WFS is caused by mutations in the 
WFS1 or WFS2 genes (OMIM 222300). WFS1 
encodes a transmembrane protein localised 
to the endoplasmic reticulum (ER) named 
wolframin, which plays a crucial role in main-
taining ER homeostasis, including calcium 
regulation, redox regulation, ER stress signal-
ling and cell death.4–8 WFS2 (also known as 
CISD2) encodes ER intermembrane small 
protein, which plays a role in ER calcium 
homeostasis.9 10 WFS is associated with lower 
volume of the brainstem as well as cerebellum 
and reduced myelination throughout the 
brain (Lugar et al; Hershey et al). WFS also 
damages afferent visual pathway neurons.11–14 
The reason for the selective neuronal damage 
remains unclear.
The Washington University WFS 
Research Study has examined a cohort of 
children, adolescents and young adults 
longitudinally.14–18 Cognitive, neurological, 
audiological and ophthalmological measures 
are performed annually using standardised 
protocols, supplemented by magnetic reso-
nance brain imaging (MRI). The current 
report describes how visual acuity, retinal 
nerve fibre layer (RNFL) thickness and the 
optic radiations of the geniculostriate cerebral 
visual pathways are affected at a cross-section 
Key messages
What is known?
The hallmarks of Wolfram syndrome are bilateral optic 
atrophy, diabetes mellitus and deafness.
What are the new findings?
 ► First report of follow-up of a large cohort of patients 
with Wolfram syndrome documenting longitudinal 
decline in visual acuity and retinal nerve fibre layer.
 ► First report showing a correlation of subnormal 
visual acuity in Wolfram syndrome with structural 
abnormalities of the optic radiations.
How might these results change the focus of 
clinical practice?
Better appreciation of postgeniculate and pregeniculate 
visual neuropathy of Wolfram syndrome to use as 
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of ages and longitudinally. A secondary goal was to show 
the wide range of disease severity evident in patients with 
WFS.
subjeCTs And MeTHods
The 23 participants were recruited through the Wash-
ington University Wolfram Syndrome Registry website 
to participate in standardised evaluations across 
domains known to be associated with WFS at an annual 
Washington University WFS Research Clinic. Minimal 
diagnostic criteria to enrol in the registry are: (A) the 
diagnosis of insulin-dependent DM and optic atrophy by 
a physician before 18 years of age or (B) genetic confir-
mation of a WFS1 mutation. Informed consent from 
parents for minor participants or from adult participants 
was obtained prior to study enrolment.
ophthalmic measures
A comprehensive quantitative ophthalmic examination 
was performed by one of the authors (JH or LT), including 
documentation of strabismus, nystagmus, binocular 
perception, pupillary function, slit lamp biomicroscopy 
and fundoscopic examination. These clinical measures 
were supplemented by laboratory testing of RNFL thick-
ness, Humphrey Visual Field Analysis, colour vision and 
fundus photography as described in detail in a previous 
report.18 Here we confine the description to testing of 
visual acuity and RNFL thickness as measures of disease 
progression. Best-corrected distance logMAR visual 
acuity (CDVA) was recorded for each subject using Early 
Treatment Diabetic Retinopathy Study optotypes.19 RNFL 
thickness was measured by Optical Coherence Tomog-
raphy (OCT, Zeiss CirrusHD-OCT, 4000–5444 version 
4.5.1.11; Carl ZeissMeditec, Dublin, California, USA). 
Normative values for RNFL thickness were obtained from 
age-matched controls tested in our laboratory who had 
normal visual acuity and no neuroretinal abnormalities.
diffusion tensor MrI (dT-MrI)
Scans were acquired in awake, unsedated patients on a 
Siemens 3T Tim Trio MRI scanner at Washington Univer-
sity. The DT-MRI echo planar sequence consisted of 27 
directions with the b-values ranging from 0 s/mm2 to 
1400 s/mm2. Transverse acquisition, TR=12 300, TE=108, 
voxel resolution=1.98×1.98 × 2 mm, time=5:44 min. 
DT-MRI optic radiation images were atlas transformed, 
and measures of white matter microstructural integrity 
(fractional anisotropy (FA)) were computed.20 21 Prob-
abilistic tractography was performed using FMRIB’s 
Diffusion Toolbox. Masks for tractography were created 
using FSLView. To track the optic radiations, masks were 
placed bilaterally on the lateral geniculate nucleus and 
the striate cortex (area V1) calcarine sulcus, and prob-
ability distributions were generated between them. The 
resulting distributions were then thresholded at 1% to 
remove extraneous pathways and converted into binary 
masks for the purpose of extracting mean FA.
statistical analysis
Variables were tested for normality using the Kolmogor-
ov-Smirnov test. Measures were obtained for each eye. 
Visual deficits in WFS are generally symmetrical17 18; in 
the cohort reported here there were no significant differ-
ences between right and left eyes for CDVA (P=0.37) or 
RNFL thickness (P=0.46). To minimise comparisons and 
improve clarity in the results, we averaged by combining 
left and right values. Relationships between age, CDVA 
and RNFL measures were assessed using Pearson’s r. 
Ophthalmological and DT-MRI measures were compared 
using the related samples Wilcoxon signed rank test for 
small sample sizes. All analyses were performed employing 
Statistical Package for the Social Sciences software (SPSS 
V.22). A P value of <0.05 was considered significant.
resulTs
For the 23 patients included in this analysis, mean age 
was 13.8 years (range, 5–25 years); median 11.3 years, 
that is, half of the patients were <12 years of age. Sixty-five 
per cent (15) were female and 35% (8) were male. Seventy 
per cent (16) were Caucasian, 13% (3) were Hispanic and 
17% (4) were mixed race. Average age at detection of 
visual impairment by an outside examiner before enrol-
ment in the study was 9.1±4.2 years (range 3–17 years). 
The average time between vision impairment detection 
and enrolment in the study was 4.8±3.7 years. Impaired 
vision and optic disc pallor (96% of patients) were diag-
nosed when children were examined by an eye care 
provider after experiencing difficulty with visual tasks in 
elementary school. The prevalence of ophthalmic find-
ings are listed in table 1. These rates are similar to those 
reported previously in a subset of this cohort.18
At entrance into the study, all 23 patients (100%) were 
able to cooperate for measurement of CDVA; RNFL 
measurement was achieved in 20 patients (87%), and 
DT-MRI scans of the optic radiations were obtained in 
19 patients (83%). The combination of low-vision-related 
Table 1 Prevalence of ophthalmic findings in the 23 




Visual acuity <0.3 logMAR 96 (22/23)
RNFL thinning ≤80 μ 100 (23/23)




Optic nerve pallor 96 (22/23)
Optic nerve cup:disc ratio ≥0.4 39 (9/23)
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unsteady visual fixation, neurodevelopmental disability 
and/or immaturity prevented testing of the RNFL 
in three patients and contraindications for MRI (eg, 
cochlear implants and braces) precluded scanning in 
four patients. Table 2 shows the number of patients who 
have been enrolled for 1–3 years and thus the number 
retested at those intervals. About half of patients (11/23) 
have 3 years of CDVA test data available for longitudinal 
analysis (table 2).
Age-related trends for visual acuity, rnFl and optic radiation 
FA
Visual acuity (CDVA) as a function of WFS patient age 
is shown in figure 1. The CDVA at entrance examina-
tion is plotted for each of the 23 patients. Lines joining 
data points represent the CDVA obtained at annual 
follow-up examinations for individual patients. CDVA was 
a mean 20/91 (logMAR: 0.66), with a range of 20/25 to 
20/40 000 (logMAR: 0.9–3.3). CDVA was 20/40 or worse 
in 91% of patients (21/23).
RNFL thickness is a measure of the health of anterior 
(pregeniculate) visual pathway axons; RNFL as a function 
of patient age is shown in figure 2. The RNFL thick-
ness at entrance examination is plotted for 20 patients 
(20/23; three children could not perform the test reli-
ably). Lines joining data points represent the CDVA 
obtained at annual follow-up examinations for individual 
patients. Seven of the 20 patients (35%) had one or 
more follow-up RNFL values that exceeded the entrance 
value (upward slope of the line joining values). It would 
be difficult to explain these upward deflections as true 
Table 2 Number of patients tested at entrance 









Visual acuity 23 18 14 11
Retinal nerve 
fibre layer
20 14 11 10
DT-MRI optic 
radiation FA
19 13 9 6
DT-MRI, diffusion tensor MRI; FA, fractional anisotropy.
Figure 1 Visual acuity (logMAR units) versus patient age. 
Lines join sequential annual measures of individual patients 
with WFS. logMAR, log minimum angle resolution; WFS, 
Wolfram syndrome.
Figure 2 Retinal nerve fibre layer (RNFL) thickness versus 
age in patients with WFS (white dots) and in age-matched 
normal subjects (black dots). Lines join sequential annual 
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increases in RNFL thickness; they likely represent ‘noise’ 
inherent in measurement of RNFL in patients who have 
subnormal vision and fixation instability. RNFL thickness 
in patients with WFS (figure 3) averaged 57±8 µ, or 40% 
thinner than that measured in normal (94±10 µ) children 
and adolescents. The difference between mean RNFL 
thickness in WFS patients versus controls was significant 
(year 1, n=20, Z score=−4.30, P<0.01). RNFL thickness 
was not correlated with CDVA (r=– 0.07, P=0.70).
Optic radiation FA measures the health of posterior 
(postgeniculate) axons (figure 4). FA is a sensitive indi-
cator of white matter injury22 and can detect damage 
even when standard MR images appear normal.23–27 In 
patients with WFS, lower optic radiation FA (figure 4) 
correlated strongly with worse CDVA (year 1, n=19, 
rs=−0.60, P=0.006).
A downward trend is evident in the regression line of 
figure 1—worse CDVA at older age—and in the regression 
line of figure 2—thinner RNFL at older age. However, the 
data of both figures show a wide range of disease severity. 
Some young patients with WFS had poor CDVA and thin 
RNFL, whereas some older patients had comparatively 
good CDVA and thicker RNFL. The range of severity 
independent of age is evident in the fact that correlation 
with age was non-significant for CDVA (P=0.44), RNFL 
(P=0.11) and optic radiation FA (P=0.94).
In normal adults, thinner RNFL has been associated 
with older age, longer axial length (AL) of the eye and 
smaller optic disc area.28 AL was not measured in our 
patients so we used spherical refractive error as a proxy; 
hyperopic eyes tend to be shorter and myopic eyes tend 
to be longer. Neither age, refractive error nor disc area 
were correlated with thinner RNFL in our Wolfram 
cohort (age, P=0.44; spherical refractive error, P=0.13; 
optic disc area, P=0.39).
There were no significant differences between male 
and female patients with regard to entrance CDVA 
(P=0.71), RNFL thickness (P=0.36) or OR FA (P=0.65).
Comparison of entrance year measures to follow-up year 
measures
To assess disease progression, measures obtained at 
entrance were compared with measures obtained in 
successive annual follow-up examinations. Because 
patients in this longitudinal cohort study are enrolled as 
they are referred to our centre, patients enrolled earlier 
in the study have longer follow-up and those enrolled 
recently have shorter follow-up. Table 1 shows the 
number enrolled (23 patients) and the lower numbers 
measured at each year of follow-up.
In the 11 patients measured annually for 3 years, CDVA 
declined significantly from a mean logMAR 0.61±0.37 to 
logMAR 0.80±0.42 (Wilcoxon signed rank test, P<0.05). 
Over the same interval, RNFL thickness declined from 
an average 59±6 µ to 55±4 µ (P<0.05). Did patients with 
worse CDVA at the entrance examination and/or thinner 
RNFL thickness at entrance examination have greater 
rates of loss at follow-up examinations? To examine this 
issue, the slope of the loss was calculated for each patient 
and then correlated with the entrance values. The slopes 
did not correlate with the entrance values, that is, the 
most severely affected patients did not have steeper rates 
of loss (CDVA mean=0.05 logMAR/year, P=0.35; RNFL 
mean=−0.3 micron/year, P=0.54).
Figure 3 Retinal nerve fibre layer mean thickness for 
patients with WFS versus controls. WFS, Wolfram syndrome.
Figure 4 Optic radiation fractional anisotropy versus 
visual acuity (logMAR units) in patients with WFS. Measures 
obtained at entrance examination. logMAR, log minimum 
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For OR FA, the decline from entrance (mean 
0.45±0.03) to 1 year follow-up (0.43±0.03; 13 patients) 
was significant (P<0.05). Lower numbers of patients at 
the 2-year and 3-year follow-up (nine patients and six 
patients, respectively) likely account for non-significant 
statistical declines at the longer OR FA retesting intervals.
dIsCussIon
The goal of the current study was to answer three ques-
tions. First, how does visual function and structure 
relate to patient age in WFS? Second, how widely does 
visual disease severity range in a sizeable cohort of WFS 
patients? Third, does visual function decline over time in 
WFS patients, for both pregeniculate regions of the visual 
pathway (RNFL) and postgeniculate regions (OR FA)?
Our results show that visual function and structure in 
WFS are related to patient age. Considering the cohort 
as a whole, younger patients tend to have better CDVA 
(figure 1) and RNFL thickness (figure 2) than older 
patients. All of the patients with WFS—from the youngest 
at age 5 years to the oldest at age 25 years at entrance into 
the study—had significantly thinner RNFL thickness 
than any of the age-matched control subjects (figure 2). 
However, the variation of disease severity within the WFS 
cohort is wide. Many younger patients have worse CDVA 
and a thinner RNFL than some older patients. In patients 
followed for 3 years, CDVA and RNFL declined signifi-
cantly. Zmysloska et al reported recently also decline 
of RNFL in patients with WFS followed on average 
22 months.29
OR FA in patients with WFS has been shown to be 
reduced significantly compared with both age-matched 
healthy and diabetic controls14 (diabetic controls are 
necessary because DM is one of the diagnostic criteria 
for WFS and DM can impair brain function and struc-
ture).27 30–33 OR FA is a sensitive indicator of postlateral 
geniculate nucleus visual axon health and myelination.22 26 
FA measures the movement of water within and parallel 
to neuronal axonal fibres. In normal children and adoles-
cents, FA increases with age.34 When axons or myelin 
are damaged, FA can decrease.23 Previous analyses have 
found that OR FA is lower in patients with WFS than in 
controls.35 We found a significant correlation between 
optic radiation FA and CDVA in our WFS patients 
(figure 4). Lower OR FA was associated with lower CDVA. 
Taken together, these results indicate damage to prege-
niculate (RNFL) and postgeniculate visual axons (OR 
FA) in WFS. The results allow better appreciation of the 
postgeniculate and pregeniculate visual neuropathy of 
WFS. These functional and structural tests may be helpful 
as outcome measures in future therapeutic trials.
In previous reports of entrance examination findings 
in a portion of this WFS cohort, the phenotypic charac-
teristics were catalogued.17 18 The visual characteristics 
included subnormal CDVA, impaired colour vision, visual 
field deficits, vision loss-related nystagmus, strabismus, 
afferent pupillary defects and optic nerve head pallor. A 
previous report of neuroimaging compared a portion of 
this WFS cohort to age-matched controls.14 That report 
documented that WFS patients have reduced brainstem 
(midbrain; pons) and cerebellar volumes at early ages. 
The reduction of RNFL thickness, OR FA, brainstem and 
cerebellar volumes at even the earliest ages imply that 
the brain abnormalities of WFS are both neurodevelop-
mental and neurodegenerative. The WFS1 mutations 
may cause hypoplasia of neurons and their axonal projec-
tions, as well as gradual atrophy of neurons. The current 
study documents that the neuronal damage—while vari-
able across patients with WFS—encompasses the anterior 
as well as the posterior visual pathway and worsens with 
age.
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